Product Information
MYCOPHENOLATE 250 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1387 per EA under NDC 59651062401. Its NADAC has been published 64 times since Apr 9, 2025.
Strength
250 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651062401
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MYCOPHENOLATE MOFETILApproval Type
Generic (ANDA)
FDA Application
ANDA217828On Market Since
1/5/2024
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLATE 250 MG CAPSULE has been published 64 times since Apr 9, 2025, and over the history we have for it it has declined 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1387 per EA |
|---|---|
| All-time high | $0.1743 (Apr 16, 2025) |
| All-time low | $0.1331 (Sep 17, 2025) |
| 52-week high | $0.1591 |
| 52-week low | $0.1331 |
| Median price | $0.1424 |
| Average price | $0.1460 |
| Largest weekly change | -7.5% (Jul 23, 2025) |
| Weeks tracked | 64 |
| Tracking since | Apr 9, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MYCOPHENOLATE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLATE 250 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.1387 per EA (NDC 59651062401), effective Jun 24, 2026.
How has the price of MYCOPHENOLATE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLATE 250 MG CAPSULE has declined 20.4%. It has been tracked across 64 weekly CMS publications since Apr 9, 2025.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLATE 250 MG CAPSULE?
Since Apr 9, 2025, the NADAC for MYCOPHENOLATE 250 MG CAPSULE has ranged from a low of $0.1331 (Sep 17, 2025) to a high of $0.1743 (Apr 16, 2025), with a median of $0.1424 per EA.
Are there cheaper alternatives to MYCOPHENOLATE 250 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as MYCOPHENOLATE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures MYCOPHENOLATE 250 MG CAPSULE?
MYCOPHENOLATE 250 MG CAPSULE (NDC 59651062401) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification